Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
41
HQL Quote, Financials, Valuation and Earnings
Last price:
$17.18
Seasonality move
:
8.25%
Day range:
$16.92 - $17.33
52-week range:
$10.55 - $17.80
Dividend yield:
10.64%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
218.2K
Avg. volume:
201.3K
1-year change:
20.25%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HQL
abrdn Life Sciences Investors
|
-- | -- | -- | -- | -- |
|
BME
BlackRock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Term Trust
|
-- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- |
|
THW
abrdn World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HQL
abrdn Life Sciences Investors
|
$17.10 | -- | -- | -- | $0.50 | 10.64% | -- |
|
BME
BlackRock Health Sciences Trust
|
$40.65 | -- | -- | -- | $0.26 | 7.74% | -- |
|
BMEZ
BlackRock Health Sciences Term Trust
|
$15.51 | -- | -- | -- | $0.11 | 12.5% | -- |
|
HQH
abrdn Healthcare Investors
|
$19.04 | -- | -- | -- | $0.57 | 11.5% | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
$18.77 | -- | -- | -- | $0.18 | 11.51% | -- |
|
THW
abrdn World Healthcare Fund
|
$12.54 | -- | -- | -- | $0.12 | 11.17% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HQL
abrdn Life Sciences Investors
|
-- | 1.407 | -- | -- |
|
BME
BlackRock Health Sciences Trust
|
-- | 0.524 | -- | -- |
|
BMEZ
BlackRock Health Sciences Term Trust
|
-- | 1.062 | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | 1.298 | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | 0.639 | -- | -- |
|
THW
abrdn World Healthcare Fund
|
-- | 0.935 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HQL
abrdn Life Sciences Investors
|
-- | -- | -- | -- | -- | -- |
|
BME
BlackRock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Term Trust
|
-- | -- | -- | -- | -- | -- |
|
HQH
abrdn Healthcare Investors
|
-- | -- | -- | -- | -- | -- |
|
THQ
abrdn Healthcare Opportunities Fund
|
-- | -- | -- | -- | -- | -- |
|
THW
abrdn World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
abrdn Life Sciences Investors vs. Competitors
-
Which has Higher Returns HQL or BME?
BlackRock Health Sciences Trust has a net margin of -- compared to abrdn Life Sciences Investors's net margin of --. abrdn Life Sciences Investors's return on equity of -- beat BlackRock Health Sciences Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HQLabrdn Life Sciences Investors-- -- -- BMEBlackRock Health Sciences Trust-- -- -- -
What do Analysts Say About HQL or BME?
abrdn Life Sciences Investors has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Health Sciences Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that abrdn Life Sciences Investors has higher upside potential than BlackRock Health Sciences Trust, analysts believe abrdn Life Sciences Investors is more attractive than BlackRock Health Sciences Trust.
Company Buy Ratings Hold Ratings Sell Ratings HQLabrdn Life Sciences Investors0 0 0 BMEBlackRock Health Sciences Trust0 0 0 -
Is HQL or BME More Risky?
abrdn Life Sciences Investors has a beta of 0.813, which suggesting that the stock is 18.69% less volatile than S&P 500. In comparison BlackRock Health Sciences Trust has a beta of 0.653, suggesting its less volatile than the S&P 500 by 34.715%.
-
Which is a Better Dividend Stock HQL or BME?
abrdn Life Sciences Investors has a quarterly dividend of $0.50 per share corresponding to a yield of 10.64%. BlackRock Health Sciences Trust offers a yield of 7.74% to investors and pays a quarterly dividend of $0.26 per share. abrdn Life Sciences Investors pays -- of its earnings as a dividend. BlackRock Health Sciences Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HQL or BME?
abrdn Life Sciences Investors quarterly revenues are --, which are smaller than BlackRock Health Sciences Trust quarterly revenues of --. abrdn Life Sciences Investors's net income of -- is lower than BlackRock Health Sciences Trust's net income of --. Notably, abrdn Life Sciences Investors's price-to-earnings ratio is -- while BlackRock Health Sciences Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for abrdn Life Sciences Investors is -- versus -- for BlackRock Health Sciences Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQLabrdn Life Sciences Investors-- -- -- -- BMEBlackRock Health Sciences Trust-- -- -- --
-
Which has Higher Returns HQL or BMEZ?
BlackRock Health Sciences Term Trust has a net margin of -- compared to abrdn Life Sciences Investors's net margin of --. abrdn Life Sciences Investors's return on equity of -- beat BlackRock Health Sciences Term Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HQLabrdn Life Sciences Investors-- -- -- BMEZBlackRock Health Sciences Term Trust-- -- -- -
What do Analysts Say About HQL or BMEZ?
abrdn Life Sciences Investors has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Health Sciences Term Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that abrdn Life Sciences Investors has higher upside potential than BlackRock Health Sciences Term Trust, analysts believe abrdn Life Sciences Investors is more attractive than BlackRock Health Sciences Term Trust.
Company Buy Ratings Hold Ratings Sell Ratings HQLabrdn Life Sciences Investors0 0 0 BMEZBlackRock Health Sciences Term Trust0 0 0 -
Is HQL or BMEZ More Risky?
abrdn Life Sciences Investors has a beta of 0.813, which suggesting that the stock is 18.69% less volatile than S&P 500. In comparison BlackRock Health Sciences Term Trust has a beta of 1.011, suggesting its more volatile than the S&P 500 by 1.13%.
-
Which is a Better Dividend Stock HQL or BMEZ?
abrdn Life Sciences Investors has a quarterly dividend of $0.50 per share corresponding to a yield of 10.64%. BlackRock Health Sciences Term Trust offers a yield of 12.5% to investors and pays a quarterly dividend of $0.11 per share. abrdn Life Sciences Investors pays -- of its earnings as a dividend. BlackRock Health Sciences Term Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HQL or BMEZ?
abrdn Life Sciences Investors quarterly revenues are --, which are smaller than BlackRock Health Sciences Term Trust quarterly revenues of --. abrdn Life Sciences Investors's net income of -- is lower than BlackRock Health Sciences Term Trust's net income of --. Notably, abrdn Life Sciences Investors's price-to-earnings ratio is -- while BlackRock Health Sciences Term Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for abrdn Life Sciences Investors is -- versus -- for BlackRock Health Sciences Term Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQLabrdn Life Sciences Investors-- -- -- -- BMEZBlackRock Health Sciences Term Trust-- -- -- --
-
Which has Higher Returns HQL or HQH?
abrdn Healthcare Investors has a net margin of -- compared to abrdn Life Sciences Investors's net margin of --. abrdn Life Sciences Investors's return on equity of -- beat abrdn Healthcare Investors's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HQLabrdn Life Sciences Investors-- -- -- HQHabrdn Healthcare Investors-- -- -- -
What do Analysts Say About HQL or HQH?
abrdn Life Sciences Investors has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Investors has an analysts' consensus of -- which suggests that it could fall by --. Given that abrdn Life Sciences Investors has higher upside potential than abrdn Healthcare Investors, analysts believe abrdn Life Sciences Investors is more attractive than abrdn Healthcare Investors.
Company Buy Ratings Hold Ratings Sell Ratings HQLabrdn Life Sciences Investors0 0 0 HQHabrdn Healthcare Investors0 0 0 -
Is HQL or HQH More Risky?
abrdn Life Sciences Investors has a beta of 0.813, which suggesting that the stock is 18.69% less volatile than S&P 500. In comparison abrdn Healthcare Investors has a beta of 0.815, suggesting its less volatile than the S&P 500 by 18.502%.
-
Which is a Better Dividend Stock HQL or HQH?
abrdn Life Sciences Investors has a quarterly dividend of $0.50 per share corresponding to a yield of 10.64%. abrdn Healthcare Investors offers a yield of 11.5% to investors and pays a quarterly dividend of $0.57 per share. abrdn Life Sciences Investors pays -- of its earnings as a dividend. abrdn Healthcare Investors pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HQL or HQH?
abrdn Life Sciences Investors quarterly revenues are --, which are smaller than abrdn Healthcare Investors quarterly revenues of --. abrdn Life Sciences Investors's net income of -- is lower than abrdn Healthcare Investors's net income of --. Notably, abrdn Life Sciences Investors's price-to-earnings ratio is -- while abrdn Healthcare Investors's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for abrdn Life Sciences Investors is -- versus -- for abrdn Healthcare Investors. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQLabrdn Life Sciences Investors-- -- -- -- HQHabrdn Healthcare Investors-- -- -- --
-
Which has Higher Returns HQL or THQ?
abrdn Healthcare Opportunities Fund has a net margin of -- compared to abrdn Life Sciences Investors's net margin of --. abrdn Life Sciences Investors's return on equity of -- beat abrdn Healthcare Opportunities Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HQLabrdn Life Sciences Investors-- -- -- THQabrdn Healthcare Opportunities Fund-- -- -- -
What do Analysts Say About HQL or THQ?
abrdn Life Sciences Investors has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn Healthcare Opportunities Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that abrdn Life Sciences Investors has higher upside potential than abrdn Healthcare Opportunities Fund, analysts believe abrdn Life Sciences Investors is more attractive than abrdn Healthcare Opportunities Fund.
Company Buy Ratings Hold Ratings Sell Ratings HQLabrdn Life Sciences Investors0 0 0 THQabrdn Healthcare Opportunities Fund0 0 0 -
Is HQL or THQ More Risky?
abrdn Life Sciences Investors has a beta of 0.813, which suggesting that the stock is 18.69% less volatile than S&P 500. In comparison abrdn Healthcare Opportunities Fund has a beta of 0.943, suggesting its less volatile than the S&P 500 by 5.709%.
-
Which is a Better Dividend Stock HQL or THQ?
abrdn Life Sciences Investors has a quarterly dividend of $0.50 per share corresponding to a yield of 10.64%. abrdn Healthcare Opportunities Fund offers a yield of 11.51% to investors and pays a quarterly dividend of $0.18 per share. abrdn Life Sciences Investors pays -- of its earnings as a dividend. abrdn Healthcare Opportunities Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HQL or THQ?
abrdn Life Sciences Investors quarterly revenues are --, which are smaller than abrdn Healthcare Opportunities Fund quarterly revenues of --. abrdn Life Sciences Investors's net income of -- is lower than abrdn Healthcare Opportunities Fund's net income of --. Notably, abrdn Life Sciences Investors's price-to-earnings ratio is -- while abrdn Healthcare Opportunities Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for abrdn Life Sciences Investors is -- versus -- for abrdn Healthcare Opportunities Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQLabrdn Life Sciences Investors-- -- -- -- THQabrdn Healthcare Opportunities Fund-- -- -- --
-
Which has Higher Returns HQL or THW?
abrdn World Healthcare Fund has a net margin of -- compared to abrdn Life Sciences Investors's net margin of --. abrdn Life Sciences Investors's return on equity of -- beat abrdn World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HQLabrdn Life Sciences Investors-- -- -- THWabrdn World Healthcare Fund-- -- -- -
What do Analysts Say About HQL or THW?
abrdn Life Sciences Investors has a consensus price target of --, signalling downside risk potential of --. On the other hand abrdn World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that abrdn Life Sciences Investors has higher upside potential than abrdn World Healthcare Fund, analysts believe abrdn Life Sciences Investors is more attractive than abrdn World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings HQLabrdn Life Sciences Investors0 0 0 THWabrdn World Healthcare Fund0 0 0 -
Is HQL or THW More Risky?
abrdn Life Sciences Investors has a beta of 0.813, which suggesting that the stock is 18.69% less volatile than S&P 500. In comparison abrdn World Healthcare Fund has a beta of 0.860, suggesting its less volatile than the S&P 500 by 13.951%.
-
Which is a Better Dividend Stock HQL or THW?
abrdn Life Sciences Investors has a quarterly dividend of $0.50 per share corresponding to a yield of 10.64%. abrdn World Healthcare Fund offers a yield of 11.17% to investors and pays a quarterly dividend of $0.12 per share. abrdn Life Sciences Investors pays -- of its earnings as a dividend. abrdn World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HQL or THW?
abrdn Life Sciences Investors quarterly revenues are --, which are smaller than abrdn World Healthcare Fund quarterly revenues of --. abrdn Life Sciences Investors's net income of -- is lower than abrdn World Healthcare Fund's net income of --. Notably, abrdn Life Sciences Investors's price-to-earnings ratio is -- while abrdn World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for abrdn Life Sciences Investors is -- versus -- for abrdn World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HQLabrdn Life Sciences Investors-- -- -- -- THWabrdn World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 69.73% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.64% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.99% over the past day.
